Posts by Sally
Contraception During COVID: California’s Medi-Cal and FamilyPACT Programs Cover Depo-SubQ Provera
We recently wrote about the importance of offering patients subcutaneous depot medroxyprogesterone acetate (DMPA-SQ) as a contactless form of contraception during the COVID-19 public health emergency. California pharmacists can prescribe…
Read MoreClinical Considerations for Contraception During COVID: Patient Self-Administration
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More2020 CDC Update for Contraceptive Use in Women at High Risk for HIV
The CDC published updated guidelines to the 2016 U.S. Medical Eligibility Criteria for Contraceptive Use regarding women at high risk for HIV infection in April 2020.
Read MoreContraception for Your Transgender Patients
Terminology Navigating through a discussion about gender and sexuality with the many terms used today can be confusing. Here is a brief introduction to terminology regarding the multifaceted gender spectrum.1…
Read MoreTwirla: A New Contraceptive Patch
Twirla is a new contraceptive patch that was approved by the FDA earlier this month on February 14, 2020.
Read MoreEndometriosis Basics and How Contraception Can Help
What is endometriosis? Endometriosis is characterized as a condition in which endometrial tissue, which normally lines the uterus, develops outside of the uterine cavity in abnormal locations such as the…
Read MoreShould We Offer Preconception Services in Community Pharmacies?
Why is preconception care important? Roughly 4 million pregnancies occur in the United States annually.1 A common misconception is that preconception care is only a health care need when there…
Read MoreTeratogenic Medications and Contraception Management
The use of prescription medications by pregnant women has increased over the past 30 years and with the usage comes an increased associated risk of exposing the fetus to the…
Read MoreNew Report Released on State Efforts to Expand Access to Contraception in Pharmacies
Download free 17-page report describing the current landscape of direct access to contraception in pharmacies, state legislative approaches and experiences, as well as implementation.
Read MoreMeet Slynd: A Novel Progestin-Only Pill
What’s this new pill? Slynd® is the new progestin-only oral contraceptive approved by the FDA in May 2019. This novel progestin-only pill (POP) contains drospirenone 4 mg in each active…
Read More